4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-015471
SVP and General Counsel sold 2,812 shares at an average $55.53 ($156,138)
- SVP and General Counsel acquired 2,812 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Taylor Stacy L · SVP and General Counsel
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-26 | Exercise or conversion : show line 1 in the form | +1,041 | $7.80 | $8,120 | 2,341 | D |
| 2021-02-26 | Exercise or conversion : show line 2 in the form | +1,771 | $6.55 | $11,600 | 4,112 | D |
| 2021-02-26 | Sale : show line 3 in the form | −1,079 | $54.47 | $58,773 | 3,033 | D |
| 2021-02-26 | Sale : show line 4 in the form | −400 | $55.46 | $22,184 | 2,633 | D |
| 2021-02-26 | Sale : show line 5 in the form | −1,333 | $56.40 | $75,181 | 1,300 | D |
| Open-market sales · 2,812 sh · avg $55.53 · $156,138 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-26 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −1,041 | 27,084 | D |
| 2021-02-26 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −1,771 | 23,021 | D |
Loading xslF345X03/doc4.xml…